Q1 2024 Holdings
Filed 2024-05-15 | 80 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $44.7M | 425,000 | 4.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $41.1M | 600,000 | 3.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $36.9M | 450,000 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $35.3M | 1,300,000 | 3.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $31.5M | 450,000 | 2.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $31.0M | 235,000 | 2.9% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $28.9M | 350,000 | 2.7% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $28.2M | 1,300,000 | 2.6% |
| Elevance Health Inc(ELV) | COM | 036752103 | $25.9M | 50,000 | 2.4% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $24.6M | 300,000 | 2.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $24.6M | 135,000 | 2.3% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $22.8M | 125,000 | 2.1% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $21.8M | 225,000 | 2.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $21.4M | 590,000 | 2.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $21.1M | 975,000 | 2.0% |
| Humana Inc(HUM) | COM | 444859102 | $20.8M | 60,000 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.7M | 150,000 | 1.9% |
| Bruker Corp(BRKR) | COM | 116794108 | $20.7M | 220,000 | 1.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $20.0M | 50,000 | 1.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $19.9M | 210,000 | 1.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $17.7M | 255,000 | 1.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $17.6M | 65,000 | 1.6% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $16.4M | 17,000 | 1.5% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $16.0M | 760,000 | 1.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $15.6M | 70,000 | 1.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $15.5M | 360,000 | 1.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $15.2M | 325,000 | 1.4% |
| Icon PLC(ICLR) | SHS | G4705A100 | $15.1M | 45,000 | 1.4% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $15.0M | 220,000 | 1.4% |
| The Cigna Group(CI) | COM | 125523100 | $14.5M | 40,000 | 1.3% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $14.2M | 80,000 | 1.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $13.9M | 100,000 | 1.3% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $13.6M | 500,000 | 1.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $13.5M | 420,000 | 1.3% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $13.0M | 40,000 | 1.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $12.8M | 500,000 | 1.2% |
| Cencora Inc(COR) | COM | 03073E105 | $12.1M | 50,000 | 1.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $11.8M | 2,250,000 | 1.1% |
| Cooper COS Inc(COO) | COM | 216648501 | $11.2M | 110,000 | 1.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $11.1M | 220,000 | 1.0% |
| Exact Sciences Corp(EXAS)Call | COM | 30063P105 | $10.4M | 150,000 | 1.0% |
| Moonlake Immunotherapeutics(MLTX)Call | CLASS A ORD | 61559X104 | $10.0M | 200,000 | 0.9% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $9.8M | 980,000 | 0.9% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $9.6M | 200,000 | 0.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.3M | 12,000 | 0.9% |
| Repligen Corp(RGEN) | COM | 759916109 | $9.2M | 50,000 | 0.9% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $9.1M | 230,000 | 0.8% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $9.0M | 550,000 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $8.8M | 150,000 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $8.7M | 125,000 | 0.8% |